BUY Laurus Labs Ltd — Shivangi Sarda, Motilal Oswal
byShivangi Sarda, Motilal OswalHorizon: NA (inferred Swing (≤2wk))24 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·27 Jul · today
Laurus Labs Q1 Results: Stock jumps after margins cross 30%, other parameters beat
NewsCnbc-Tv18·24 Jul · 2d ago
Laurus Labs announced its Q1 FY27 financial results, reporting a revenue of ₹2,026 Cr, a 29% increase year-on-year. EBITDA stood at ₹644 Cr, up 66% with margins at 31.8%. The company highlighted stron
NSE · Press Release·24 Jul · 2d ago
Nifty in oversold territory; pullback to 24,000 possible: Analysts
NewsEt-Markets·27 Jul · today
Laurus Labs Limited has disclosed information regarding a composite scheme of arrangement involving its subsidiaries, Laurus Synthesis Private Limited and Sriam Labs Private Limited. The National Comp
BSE · Company Update·25 Jul · yesterday
Q1 Results Today Highlights: Tata Consumer con. PAT up 28.4%, ACC PAT declines 61.5%, Shriram Finance, Hindustan Zinc, SBI Life, SBI Cards, Laurus Labs Q1 profit rise
NewsHbl·24 Jul · 2d ago
Laurus Labs Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The press release is enclosed for information.
BSE · Company Update·24 Jul · 2d ago
Laurus Labs Ltd announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved at a Board Meeting held on July 24,
BSE · Board Meeting·24 Jul · 2d ago
1 advisor has an active short-term SELL call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·27 Jul · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.